Newer diagnostic techniques reduced unnecessary harm in prostate cancer testing
Independent - 23-Feb-202367% fewer men experienced risks of screening with advanced diagnostic techniques
Join the club for FREE to access the whole archive and other member benefits.
Professor of Oncogenetics at The Institute of Cancer Research
Rosalind Eeles is currently working as Professor of Oncogenetics at The Institute of Cancer Research and an Honorary Consultant in Clinical Oncology and Cancer Genetics at The Royal Marsden NHS Foundation Trust. She is a clinician as well as a scientist, working as a team leader at The ICR and a Cancer Genetics and Uro-Oncology Clinic at the ICR’s partner hospital. Eeles has been instrumental in ensuring new discoveries in cancer genetics, immediately benefit patients, particularly in her speciality areas of BRCA-mutation, other gene-mutation carriers and prostate cancer.
She is a Fellow of The Royal College of Physicians of London, The Academy of Medical Sciences in London, and The Royal College of Radiologists (Clinical Oncology Faculty), UK. Her research training was in genetic predisposition to cancer at the ICR and she has a PhD in Cancer Genetics from The University of London.
Visit website: https://www.icr.ac.uk/our-research/researchers-and-teams/professor-rosalind-eeles
See also: The Institute of Cancer Research (ICR) - One of the world’s most influential cancer research organizations
Details last updated 09-Jul-2023
67% fewer men experienced risks of screening with advanced diagnostic techniques